Stemedica Awarded U.S. Patent for Transgenic Therapeutic Stem Cells – PR Newswire (press release)
|
Stemedica Awarded U.S. Patent for Transgenic Therapeutic Stem Cells
PR Newswire (press release) Stemedica Cell Technologies, Inc. is a specialty biopharmaceutical company which manufactures best-in-class allogeneic adult stem cells and stem cell factors. The company is a government licensed manufacturer of cGMP, clinical-grade stem cells . |
